APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $292,604 | -57.4% | 7,692 | +2.1% | 0.00% | -50.0% |
Q2 2023 | $686,439 | -45.2% | 7,535 | -60.3% | 0.00% | -50.0% |
Q1 2023 | $1,251,525 | +6.9% | 18,974 | -16.2% | 0.00% | 0.0% |
Q4 2022 | $1,170,559 | -18.7% | 22,637 | +7.4% | 0.00% | -33.3% |
Q3 2022 | $1,439,000 | +72.1% | 21,068 | +13.8% | 0.01% | +100.0% |
Q2 2022 | $836,000 | -30.7% | 18,510 | -22.0% | 0.00% | 0.0% |
Q1 2022 | $1,207,000 | -12.3% | 23,745 | -18.5% | 0.00% | 0.0% |
Q4 2021 | $1,377,000 | +55.4% | 29,151 | +8.4% | 0.00% | +50.0% |
Q3 2021 | $886,000 | -55.2% | 26,894 | -14.1% | 0.00% | -66.7% |
Q2 2021 | $1,979,000 | +69.7% | 31,313 | +15.2% | 0.01% | +50.0% |
Q1 2021 | $1,166,000 | -18.5% | 27,179 | +8.7% | 0.00% | -20.0% |
Q4 2020 | $1,430,000 | +142.4% | 24,993 | +27.9% | 0.01% | +66.7% |
Q3 2020 | $590,000 | -10.7% | 19,547 | -3.4% | 0.00% | -25.0% |
Q2 2020 | $661,000 | +80.6% | 20,227 | +48.1% | 0.00% | +33.3% |
Q1 2020 | $366,000 | -41.5% | 13,656 | -33.2% | 0.00% | 0.0% |
Q4 2019 | $626,000 | +14.2% | 20,436 | -10.2% | 0.00% | 0.0% |
Q3 2019 | $548,000 | -3.0% | 22,749 | +2.1% | 0.00% | 0.0% |
Q2 2019 | $565,000 | +26.1% | 22,278 | -3.1% | 0.00% | 0.0% |
Q1 2019 | $448,000 | +48.3% | 22,995 | +0.6% | 0.00% | +50.0% |
Q4 2018 | $302,000 | – | 22,868 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |